Mutflash - Medizinische Argumentationen und Studiensammlungen
1.25K subscribers
11.3K photos
1.89K videos
255 files
10.8K links
Unser Hauptkanal:

https://t.me/Mutflash

P.s.: Leute die ohne eine vernünftige Grundlagenargumentation gegen Biom/ Virom argumentieren sind UNwillkommen!
Download Telegram
Der Rezeptor wäre also Renin und Angiotensin (AT1/2R) (ergibt doch gleich viel mehr Sinn?).

Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review

https://link.springer.com/article/10.1007/s00280-024-04686-0

Btw: Guckt mal wohin das Ganze geht. Narf! MAPk? mTOR? JAK/STATs?
Reminder

The current understanding of KRAS protein structure and dynamics (2020)

"Hyperactivation of RAS signalling, which may occur via a direct mutation of RAS or indirectly via other proteins in RAS pathways, plays a significant role in cancer and in particular rare diseases such as RASopathies [5]. There are three closely related RAS isoforms: HRAS, KRAS and NRAS. From all of the RAS isoforms, KRAS is the most oncogenic with its 85% share of all mutated RAS proteins observed in cancer [5], [6]. KRAS missense mutations are particularly frequent in the pancreatic, colorectal and lung cancers (COSMIC v.90) [7]. In cancer, three mutation hotspots: G12, G13 and Q61 are observed in RAS genes. In this regard, KRAS differs from the NRAS and HRAS, as it is the only RAS isoform where the position 12 mutations are predominant [6]."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965201/

Gnihihi. "Follow the science"
Kleiner Reminder, dass die DARPA knietief in der Scheißeshow "Plandemie" drinsteckt und somit "die westlichen Werte"™/ "unsere Demokratie"™:

"To direct health innovation towards public health priorities and ensure availability and access, health and innovation policies can be guided by a mission-oriented framework. COVID-19 has demonstrated that missionoriented innovation agencies, such as the United States Defense Advanced Research Projects Agency (DARPA), can enhance the role of the state in coordinating public and private sectors. In health, the recently proposed Health Advanced Research Projects Agency (HARPA) offers a feasible model for lean and autonomous bureaucratic structures that provide freedom to pursue any and all innovations (and in the process lead to a significant spillover effect on other sectors) while also being driven by outcomes towards specific missions. The United States Biomedical Advanced Research and Development Authority (BARDA) demonstrates another key attribute of missionoriented agencies in public procurement: when missions create innovative solutions, they also directly create market demand that self-enforces the need for further innovations."

https://cdn.who.int/media/docs/default-source/council-on-the-economics-of-health-for-all/who_councileh4a_councilbrief-no1_re-edition_1.pdf?sfvrsn=72ff5801_5&download=true
🔥1
"We learned that Drs. Fauci, Collins, and Farrar – all funders who advocated for gain-of-function research of concern – didn’t notify then-CDC director Robert Redfield, who opposed gain-of-function research of concern, but they did invite Ron Fouchier, Christian Drosten, and others in an academic lobbying group that advocated for gain-of-function research of concern. For those of us scientists who know these scientists involved, the actions of funders on that fateful Feb 1 call sent a clear signal that he was interested in huddling with lobbyists who also faced significant risks to their reputations if this virus came from research activities they all advocated for."

https://brownstone.org/articles/the-nature-of-lab-origin-investigations/
👍4